Novel Parameters for the Prediction of Ventriculoperitoneal Shunting Efficacy in Patients With iNPH
Key facts
- Who runs it
- University of Zurich
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 70 people, planned
- Started
- Jun 2015
- Ended
- Dec 2024
- Type of study
- Interventional
- Treatments tested
- Gait analysis and MRI:
- Record updated
- 30 April 2026
Who can take part
- Age
- 50 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Informed consent
- Age 50 years or above
- Impaired walking function for at least 3 months, onset at/ after 40 years of age
- MRI or CT with enlarged ventricular system (Evans' index ≥0.30) without evidence of moderate or severe cortical atrophy
- Eligible for shunt surgery
- Eligible for analysis of gait, neuropsychological and urological function
- Subjects must be able to understand the patient information sheet and comply with the requirements of the protocol
Who cannot take part
- Previous intracranial disorder or surgery
- Contraindications to surgery or MRI
- Presence of concomitant disease which might reasonably account for the clinical symptoms or radiological findings
- Worsening of walking function secondary to any other condition occurring during the study
- Contraindications to the testing of gait, bladder or neuropsychological function
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
INPH is a chronic, progressive disease characterised by enlarged ventricles in the absence of elevated intracranial pressure. Patients often present with the Hakim triad comprising gait disturbance, dementia and urinary incontinence. Treatment consists of ventriculoperitoneal (VP) shunting reducing the cerebrospinal fluid (CSF) volume in the central nervous system (CNS); a generally safe and well tolerated procedure nevertheless invasive in nature and associated with surgical risk. The currently used diagnostic algorithms to predict surgery outcome by testing patients before and after a diagnostic spinal tap temporarily reducing the CSF volume in the CNS are of wide variability and limited validity. Developing measures to accurately diagnose and select patients for intervention is thus of great importance. The objective of this study is to define and validate a diagnostic algorithm for the selection of patients with symptoms compatible with iNPH for shunt surgery.
The group in the trial
- Gait analysis and MRIOther group
* Gait analysis: Intervention: Treadmill with pressure sensors (FDM-THM-M-System (Force distribution method-treadmill); 'Zebris' medical GmbH), study-specific, but routine procedures. * MRI: Intervention: Performed in a scanner at the University Hospital with standard MRI compatibility procedures; study specific is only the additional MRI after the CSF release with spinal tap or drainage.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective Single-centre Trial Investigating Novel Parameters for the Prediction of Ventriculoperitoneal Shunting Efficacy in Patients With Idiopathic Normal Pressure Hydrocephalus
- Record updated
- 30 April 2026